Page last updated: 2024-08-21

pyrazines and brd4770

pyrazines has been researched along with brd4770 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
de Assuncao, TM; Dusetti, N; Iovanna, J; Lomberk, G; Mathison, A; Salmonson, A; Toro-Zapata, J; Urrutia, G; Urrutia, R	1

Other Studies

1 other study(ies) available for pyrazines and brd4770

Article	Year
Combined Targeting of G9a and Checkpoint Kinase 1 Synergistically Inhibits Pancreatic Cancer Cell Growth by Replication Fork Collapse. Molecular cancer research : MCR, 2020, Volume: 18, Issue:3 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Benzimidazoles; Carcinoma, Pancreatic Ductal; Checkpoint Kinase 1; DNA Replication; Drug Synergism; Enzyme Inhibitors; Female; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; Humans; Mice; Mice, Nude; Molecular Targeted Therapy; Pancreatic Neoplasms; Pyrazines; Pyrazoles; Random Allocation; Xenograft Model Antitumor Assays	2020

Article

Year

Combined Targeting of G9a and Checkpoint Kinase 1 Synergistically Inhibits Pancreatic Cancer Cell Growth by Replication Fork Collapse.

Molecular cancer research : MCR, 2020, Volume: 18, Issue:3

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Benzimidazoles; Carcinoma, Pancreatic Ductal; Checkpoint Kinase 1; DNA Replication; Drug Synergism; Enzyme Inhibitors; Female; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; Humans; Mice; Mice, Nude; Molecular Targeted Therapy; Pancreatic Neoplasms; Pyrazines; Pyrazoles; Random Allocation; Xenograft Model Antitumor Assays

2020